Bridgeway Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,750
Closed -$1.46M – 1283
2026
Q2
$1.46M Sell
2,750
-80
-3% -$36.9K 0.03% 648
2026
Q1
$1.36M Sell
2,830
-2,560
-47% -$1.31M 0.03% 635
2025
Q4
$3.03M Buy
+5,390
New +$3.06M 0.06% 385
2024
Q4
– Sell
-4,480
Closed -$1.5M – 1264
2024
Q3
$1.5M Hold
4,480
– – 0.03% 587
2024
Q2
$1.85M Hold
4,480
– – 0.04% 533
2024
Q1
$1.81M Buy
+4,480
New +$1.58M 0.04% 602
2022
Q4
– Sell
-2,600
Closed -$409K – 1423
2022
Q3
$409K Hold
2,600
– – 0.01% 943
2022
Q2
$389K Hold
2,600
– – 0.01% 932
2022
Q1
$425K Hold
2,600
– – 0.01% 980
2021
Q4
$566K Hold
2,600
– – 0.01% 944
2021
Q3
$492K Sell
2,600
-300
-10% -$54.7K 0.01% 1034
2021
Q2
$512K Hold
2,900
– – 0.01% 1057
2021
Q1
$476K Sell
2,900
-100
-3% -$15.3K 0.01% 1096
2020
Q4
$418K Hold
3,000
– – 0.01% 1011
2020
Q3
$335K Sell
3,000
-900
-23% -$104K 0.01% 1025
2020
Q2
$363K Buy
+3,900
New +$332K 0.01% 969

Other funds holding MEDP

Bridgeway Capital Management's MEDP Position: Q3 2026 in Review

Bridgeway Capital Management sold out of Medpace (MEDP) in Q3 2026, closing a stake of 2,750 shares — an estimated $1.46M sold.

Bridgeway Capital Management first reported a position in MEDP in Q2 2020 and held it in 16 quarters. The position peaked at $3.03M in Q4 2025. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Bridgeway Capital Management reported no remaining Medpace position as of Q3 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 2,750 Medpace shares in Q3 2026, an estimated $1.46M.
  • Bridgeway Capital Management first reported a position in Medpace in Q2 2020 and held it in 16 quarters.
  • Bridgeway Capital Management's Medpace position peaked at $3.03M in Q4 2025.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.